Summing the risk of NSAID therapy

被引：66

作者：

Scheiman, James M. ^{[1
]}

Fendrick, A. Mark

机构：

[1] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Sch Med, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Sch Publ Hlth, Dept Internal Med, Ann Arbor, MI 48109 USA

来源：

LANCET | 2007年 / 369卷 / 9573期

关键词：

D O I：

10.1016/S0140-6736(07)60722-3

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1580 / 1581

页数：2

共 14 条

[1]

ANTMAN EM, 2007, CIRCULATION 0226

[2]

Celecoxib for the prevention of colorectal adenomatous polyps [J].

Arber, Nadir ;

Eagle, Craig J. ;

Spicak, Julius ;

Racz, Istvan ;

Dite, Petr ;

Hajer, Jan ;

Zavoral, Miroslav ;

Lechuga, Maria J. ;

Gerletti, Paola ;

Tang, Jie ;

Rosenstein, Rebecca B. ;

Macdonald, Katie ;

Bhadra, Pritha ;

Fowler, Robert ;

Wittes, Janet ;

Zauber, Ann G. ;

Solomon, Scott D. ;

Levin, Bernard .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :885-895

[3]

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[4]

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial [J].

Chan, Francis Ka Leung ;

Wong, Vincent Wai Sun ;

Suen, Bing Yee ;

Wu, Justin Che Yuen ;

Ching, Jessica Yuet Ling ;

Hung, Lawrence Cheung Tsui ;

Hui, Aric Josun ;

Leung, Vincent King Sun ;

Lee, Vivian Wing Yan ;

Lai, Larry Hin ;

Wong, Grace Lai Hung ;

Chow, Dorothy Kai Lai ;

To, Ka Fa ;

Leung, Wai Keung ;

Chiu, Philip Wai Yan ;

Lee, Yuk Tong ;

Lau, James Yun Wong ;

Chan, Henry Lik Yuen ;

Ng, Enders Kwok Wai ;

Sung, Joseph Jao Yiu .

LANCET, 2007, 369 (9573) :1621-1626

[5]

Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: A decision analysis [J].

Fendrick, AM ;

Bandekar, RR ;

Chernew, ME ;

Scheiman, JM .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (01) :36-43

[6]

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].

Grosser, T ;

Fries, S ;

FitzGerald, GA .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15

[7]

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials [J].

Kearney, Patricia M. ;

Baigent, Colin ;

Godwin, Jon ;

Halls, Heather ;

Emberson, Jonathan R. ;

Patrono, Carlo .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553) :1302-1305

[8]

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison [J].

Laine, Loren ;

Curtis, Sean P. ;

Cryer, Byron ;

Kaur, Amarjot ;

Cannon, Christopher P. .

LANCET, 2007, 369 (9560) :465-473

[9]

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT) [J].

Martin, Barbara K. ;

Breitner, John C. S. ;

Evans, Denis ;

Lyketsos, Constantine G. ;

Meinert, Curtis L. .

PLOS CLINICAL TRIALS, 2006, 1 (07)

[10]

*PRECISION, PROSP RAND EV CEL IN

← 1 2 →